List of the Best Biotech Companies in India 2026
The Indian biotechnology industry has grown rapidly, increasing from a value of $10 bn in 2014 to around $165.7 bn in 2024, with an annual growth rate of 17.9%. Looking ahead, the sector is expected to reach $300 bn by 2030, driven by advances in biomanufacturing, sustainability efforts, and innovation. In this article, we will cover some of the best biotech companies in India that may benefit from the growth of the Indian biotechnology industry.
Top Biotech Stocks
Saturday, 13 June, 2026
| symbol | Company | ticker | slug | Sector | Market Price | 52W High | 52W Low | Market Cap (Cr.) | PE Ratio | Industry PE | PB Ratio | Div. Yield (%) | ROE (%) | 1YReturns | 3YReturns | 5YReturns | Market Cap Label | Industry Group | Industry | Sub Industry | percentageChange |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMIO | Acutaas Chemicals Ltd | ACUTAAS | /stocks/ami-organics-AMIO | Biotechnology | 3,145.30 | 3,444.30 | 1,059.00 | 25,750.92 | 72.28 | 41.95 | 19.51 | 0.16 | 15.85 | 185.21 | 392.26 | 572.79 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Pharmaceuticals | 0.55 |
| ANTH | Anthem Biosciences Ltd | ANTHEM | /stocks/anthem-biosciences-ANTH | Biotechnology | 780.05 | 873.50 | 579.15 | 43,932.03 | 74.23 | 41.70 | 18.23 | 0.25 | 20.82 | 6.80 | 6.80 | 6.80 | Midcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Life Sciences Tools & Services | 1.11 |
| BION | Biocon Ltd | BIOCON | /stocks/biocon-BION | Biotechnology | 419.00 | 440.40 | 331.00 | 67,857.36 | 175.98 | 41.95 | 2.45 | 0.09 | 3.82 | 18.95 | 75.24 | 1.69 | Midcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Biotechnology | 0.73 |
| GENES | CCME Global Ltd | CCME | /stocks/genesis-ibrc-india-GENES | Biotechnology | 94.00 | 184.90 | 21.22 | 122.20 | -172.11 | 41.95 | 14.33 | 0.00 | 51.77 | 342.98 | 737.79 | 1,160.05 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Biotechnology | 3.81 |
| HEST | Hester Biosciences Ltd | HESTERBIO | /stocks/hester-biosciences-HEST | Biotechnology | 1,952.90 | 2,350.00 | 1,239.30 | 1,661.31 | 29.86 | 41.95 | 5.09 | 0.56 | 8.73 | 4.92 | 19.50 | -25.79 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Biotechnology | -0.36 |
| KIL | 3B Blackbio DX Ltd | 3BBLACKBIO | /stocks/kilpest-india-KIL | Biotechnology | 1,245.40 | 1,750.00 | 1,085.00 | 1,068.89 | 18.24 | 41.95 | 3.94 | 0.40 | 19.21 | -21.73 | 181.10 | 181.03 | Smallcap | Materials | Biotechnology | Fertilizers & Agricultural Chemicals | -0.69 |
| ONE | Onesource Specialty Pharma Ltd | ONESOURCE | /stocks/onesource-specialty-pharma-ONE | Biotechnology | 1,651.40 | 2,248.00 | 1,057.00 | 18,932.61 | -256.50 | 41.70 | 3.22 | 0.00 | -0.57 | -19.50 | -3.43 | -3.43 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Life Sciences Tools & Services | -2.36 |
| PNCA | Panacea Biotec Ltd | PANACEABIO | /stocks/panacea-biotec-PNCA | Biotechnology | 536.00 | 647.00 | 292.40 | 3,283.04 | -611.37 | 41.95 | 3.92 | 0.00 | -1.00 | 17.82 | 308.69 | 35.64 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Biotechnology | 2.62 |
| SAILI | Sai Life Sciences Ltd | SAILIFE | /stocks/sai-life-sciences-SAILI | Biotechnology | 1,181.20 | 1,239.50 | 716.60 | 25,055.08 | 71.81 | 41.70 | 11.77 | 0.00 | 10.96 | 53.43 | 54.48 | 54.48 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Life Sciences Tools & Services | 3.12 |
| ZEN | Zenotech Laboratories Ltd | ZENOTECH | /stocks/zenotech-laboratories-ZEN | Biotechnology | 44.00 | 67.00 | 33.55 | 269.02 | -251.42 | 41.95 | 2.80 | 0.00 | 6.01 | -29.67 | -16.92 | 6.54 | Smallcap | Pharmaceuticals, Biotechnology & Life Sciences | Biotechnology | Biotechnology | 0.00 |
Disclaimer: Please note that the above list is for educational purposes only, and is not recommendatory. Please do your own research or consult your financial advisor before investing.
Note: The data in the above table is dynamic in nature and subject to real-time changes. This data is derived from Tickertape Stock Screener.
Selection Criteria – Biotechnology | Market Cap: Sorted from Highest to Lowest
Explore screensWhat are Biotech Stocks?
Biotech stocks are shares in companies that use biological processes to develop products, mainly in healthcare, agriculture, and pharmaceuticals. These companies work on innovative solutions like discovering new drugs, gene therapy, and creating advanced diagnostic tools.
Overview of the Top Biotech Stocks
- Biocon Ltd: Founded in 1978 by Kiran Mazumdar-Shaw, Biocon Ltd is one of India’s top biotechnology companies. Biocon focuses on developing affordable biopharmaceuticals, including drugs for diabetes, cancer, and autoimmune diseases.
- Anthem Biosciences Ltd: Founded in 2003, Anthem Biosciences Ltd is a biotechnology company based in Bangalore. It specialises in contract research and manufacturing services.
- Onesource Specialty Pharma Ltd: Onesource Specialty Pharma Ltd was founded in 2014, and it focuses on manufacturing and developing specialised generic drugs and pharmaceutical ingredients.
- Sai Life Sciences Ltd:Founded in 1999, Sai Life Sciences Ltd provides services to pharmaceutical companies worldwide, helping them with drug discovery, development, and manufacturing of complex molecules.
- Acutaas Chemicals Ltd: Acutaas Chemicals Ltd, established in 2008, manufactures speciality chemicals and biotech products for industries like agriculture, healthcare, and the environment.
Union Budget 2026-27 for the Biotech Sector
In the Union Budget 2026-27, presented on 1st February 2026, Finance Minister Nirmala Sitharaman announced measures to strengthen India’s biotech and biopharma ecosystem. The focus was on biologics, biosimilars, advanced manufacturing, clinical research, and regulatory capacity.
- Launch of Biopharma SHAKTI: The Budget proposed the Biopharma SHAKTI programme with an outlay of ₹10,000 crore over five years to strengthen India’s biologics and biosimilars ecosystem.
- Focus on Biologics and Biosimilars: The scheme aims to boost domestic production of complex biologic medicines and biosimilars, helping India move beyond traditional generic medicines into higher-value biopharma manufacturing.
- Clinical Trial Network Expansion: The Budget proposed establishing over 1,000 accredited clinical trial sites to improve research capacity and support the faster development of new therapies.
- NIPER Expansion and Upgradation: The government announced 3 new National Institutes of Pharmaceutical Education and Research (NIPERs) and the upgradation of 7 existing institutes to strengthen pharma and biotech education, skills, and innovation.
- Regulatory Strengthening: Budget measures also include strengthening the drug regulatory system, including CDSCO, to improve approval timelines and align India’s biopharma standards with global practices.
How to Invest in Biotech Stocks in India?
Here is how you can invest in the best biotech shares in India:
- Open a demat/trading/stockbroker account. You can open a demat account with smallcase!
- Conduct thorough research into the top biotech stocks in India using Tickertape Stocks Screener. The screener offers over 200 built-in filters, allowing investors to select parameters and generate a list of biotechnology stocks in India.
- Place a ‘Buy’ Order
Benefits of Investing in Biotech Stocks
- Strong Demand for Healthcare: With more people needing healthcare due to ageing and chronic diseases, biotech companies that offer new treatments or cures are in high demand. This can lead to strong growth and good returns on investments.
- Growing Biotech Market: India’s biotechnology market was valued at about $ 37.1 bn in 2025 and is expected to grow at a CAGR of 13.09% between 2026 and 2034. This growth can support companies involved in biopharma, bio-agriculture, diagnostics, and industrial biotechnology
- Diverse Sector Exposure: Biotech stocks cover multiple areas, including pharmaceuticals, diagnostics, vaccines, biologics, biosimilars, medical devices, and bio-agriculture. This gives market participants exposure to different parts of the healthcare and life sciences value chain.
- Global Market Opportunity: The global biotechnology market was valued at $1.55 tn in 2023 and is projected to reach $3.88 tn by 2030. Indian biotech companies with export capabilities, research partnerships, or global approvals may benefit from this wider opportunity.
Risks of Investing in Biotech Stocks
- Regulatory Hurdles: Biotech companies must pass strict inspections from regulators like the US FDA and India’s DCGI. Getting approval for new drugs and therapies can take years, and delays or rejections may impact a company’s stock price and financial stability.
- Dependence on R&D Success: Biotech companies rely heavily on their R&D efforts. If their drugs or treatments fail clinical trials, they may never reach the market, causing big losses for investors. The failure rate in biotech research is high, making it a risky sector for investment.
- Market Competition: The biotech industry is very competitive. Many companies are working on similar treatments, and new players constantly enter the market. This competition can pressure prices or lead to a loss of market share, which can hurt a company’s stock performance.
Factors to Consider Before Investing in Biotech Stocks
- Track Record of Research: Looking at a company’s past research achievements can help investors understand its potential for future success. Companies with a history of successfully launching products are more likely to keep doing well and bring new innovations to market.
- Regulatory Environment: The regulatory environment plays a key role in biotech investments. In India, agencies like SEBI and the DCGI oversee how biotech companies can introduce their products. Understanding these regulations is important for assessing a company’s ability to succeed in the market.
- Company’s Pipeline: A biotech company’s strength lies in its research and development pipeline. A company with a broad range of products at different stages, from early research to clinical trials, is generally considered less risky compared to one that depends on just one drug or product.
Can't decide which stocks to pick?
smallcase offers 500+ readymade stock baskets, created and managed by SEBI-registered investment experts
Try smallcase
smallcases are readymade model portfolios of stocks/ETFs, that are based on a theme, idea or strategy. They’re created and managed by SEBI-registered investment experts (also known as smallcase managers).
Among the 500+ expert-curated portfolios, here are a few popular smallcases among new investors:
Disclosures for aforementioned smallcases
To Wrap It Up…
The biotech sector offers great potential because of its constant innovation and growing demand for new healthcare solutions. However, there are risks, like strict regulations, market competition, and market changes that can affect the performance of biotechnology stocks.
That’s why it’s important to do thorough research before investing in biotech stocks. Tools like Tickertape, with over 200 filters to analyse stocks, can help investors make more informed decisions and better navigate the risks associated with this sector.
Discover ready-made stock baskets on smallcase
smallcase offers simple, quick & delightful investing for you with 200+ readymade stock baskets, created and managed by SEBI-registered investment experts
Frequently Asked Questions About Biotech Stocks in India
1. What are biotech stocks?
Biotech stocks refer to shares of companies that are involved in the research, development, and production of biotechnology products. These can include drugs, vaccines, diagnostics, and agricultural products.
2. Who is the biggest biotech company in India?
Based on the market capitalisation as of 11th May 2026, the biggest biotech company in India is Biocon Limited. Biocon is a global leader in biopharmaceuticals, including biosimilars, and is known for its research in diabetes, oncology, and immunology.
3. What are the top 5 biotech stocks?
Some of the best biotech stocks in India as of 11th May 2026, sorted by market capitalisation, include:
- Biocon Ltd
- Anthem Biosciences Ltd
- Sai Life Sciences Ltd
- Acutaas Chemicals Ltd
- Onesource Specialty Pharma Ltd
Disclaimer: Please note that the above list is for educational purposes only, and is not recommendatory.
4. What are the advantages of investing in biotech stocks?
Biotech stocks provide exposure to areas such as biologics, biosimilars, diagnostics, vaccines, and medical research. The sector may benefit from rising healthcare demand, government support for biotech manufacturing, increasing R&D activity, and growth in global healthcare markets.
5. Are biotech stocks risky?
Whether biotech stocks are risky or not depends on several factors, such as the individual company’s performance, market conditions, regulatory approvals, competition, and the company’s financial health.
6. Are there any biotech penny stocks in India?
As of 11th May 2026, Biogen Pharmachem Industries Ltd and Transgene Biotek Ltd are trading below ₹10 and can be considered penny biotech stocks.
Disclaimer: The information above is intended solely for educational purposes and should not be taken as a recommendation.
7. What factors affect biotech share prices?
Biotech share prices are influenced by multiple factors, including clinical trial results, regulatory approvals, product launches, research pipeline progress, and quarterly earnings. Government policies, healthcare demand, export growth, patent developments, and partnerships with global pharmaceutical companies can also impact valuations.
8. What are the risks of investing in biotech stocks?
Biotech stocks can be affected by factors such as regulatory delays, clinical trial failures, pricing pressure, patent expiries, and changes in healthcare policies. Many biotech businesses also depend heavily on research outcomes and product approvals, which can impact revenue visibility.
9. Who should consider biotech stocks?
Biotech stocks are generally followed by market participants interested in healthcare, pharmaceuticals, medical innovation, and research-driven businesses. Since the sector can be influenced by clinical, regulatory, and global healthcare developments, it may require close tracking of industry-specific factors before making any investment-related decision.
Disclaimer: The information provided is for educational purposes only and should not be considered investment advice or a recommendation.
Explore the Popular Stock Collections:
Thematic Stocks:
Keep yourself informed and up-to-date on a variety of thematic sectors by reading the articles below:
Indices and Market Movers:
Stocks Under Budget:
If you are looking for stocks under a particular price range, here’s the collection of stocks under a specifc budget:
